Solvay could seek buyer for pharma unit
This article was originally published in Scrip
Executive Summary
Solvay has told employees that it would consider selling its pharmaceutical business amid rumours that Sanofi-Aventis is interested in acquiring the company. In a memo, Solvay said it was mulling over its options "as opportunities are scarce and the required financial resources are significant" for the pharmaceutical division.